BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 18477900)

  • 1. Adequacy of sentinel node procedure in patients with synchronous primary skin melanoma: report of a patient with five melanomas.
    Nejc D; Chalubinska J; Piekarski J; Pluta P; Pasz-Walczak G; Kusmierek J; Berner A; Sek P; Bilski A; Durczynski A; Jeziorski A
    Melanoma Res; 2008 Jun; 18(3):235-9. PubMed ID: 18477900
    [No Abstract]   [Full Text] [Related]  

  • 2. Sentinel lymph node biopsy in the staging of two synchronous primary melanomas.
    de Tomás J; Beato MJ; Bittini A; Escat JL
    Eur J Surg; 2002; 168(4):251-3. PubMed ID: 12440765
    [No Abstract]   [Full Text] [Related]  

  • 3. Sentinel lymph node biopsy and completion lymph node dissection for malignant melanoma are not standard of care.
    Coldiron BM; Dinehart S; Rogers HW
    Clin Dermatol; 2009; 27(4):350-4. PubMed ID: 19539161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double primary malignant melanoma on the forearm and the chest with detection of common axillary sentinel lymph nodes.
    Nakamura Y; Ishizuki S; Iwasaki R; Ishitsuka Y; Watanabe R; Saito A; Furuta J; Okiyama N; Fujisawa Y
    J Dermatol; 2020 May; 47(5):e187-e188. PubMed ID: 32133678
    [No Abstract]   [Full Text] [Related]  

  • 5. [Synchronous multiple primary melanoma are often missed. Increased attention to the patient's entire skin is required for early diagnosis].
    Lapins J; Emtestam L; Hedblad MA; Girnita A; Lindelöf B; Ljung A; Hansson J
    Lakartidningen; 2013 Feb 20-26; 110(8):410-2. PubMed ID: 23488436
    [No Abstract]   [Full Text] [Related]  

  • 6. An erythematous and pigmented lesion of the abdomen--quiz case.
    Lim JL; Solky BA; Sober AJ; Duncan LM
    Arch Dermatol; 2006 Apr; 142(4):515-20. PubMed ID: 16618876
    [No Abstract]   [Full Text] [Related]  

  • 7. Particularities in managing melanoma patients with tattoos: case report and review of the literature.
    Gall N; Bröcker EB; Becker JC
    J Dtsch Dermatol Ges; 2007 Dec; 5(12):1120-1. PubMed ID: 17919304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sentinel lymph node biopsy for patients with diagnostically controversial Spitzoid melanocytic tumors?
    Busam KJ; Pulitzer M
    Adv Anat Pathol; 2008 Sep; 15(5):253-62. PubMed ID: 18724099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous melanoma in the elderly.
    Testori A; Soteldo J; Sances D; Mazzarol G; Trifirò G; Zonta M; Rastrelli M; Schenone F; Verrecchia F
    Melanoma Res; 2009 Jun; 19(3):125-34. PubMed ID: 19381113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour regression does not increase the risk of sentinel node involvement in thin melanomas.
    Cecchi R; Pavesi M; Buralli L; Innocenti S; De Gaudio C
    Chir Ital; 2008; 60(2):257-60. PubMed ID: 18689175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphatic invasion detected by D2-40/S-100 dual immunohistochemistry does not predict sentinel lymph node status in melanoma.
    Petitt M; Allison A; Shimoni T; Uchida T; Raimer S; Kelly B
    J Am Acad Dermatol; 2009 Nov; 61(5):819-28. PubMed ID: 19836642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sentinel lymph node biopsy for malignant melanoma as day surgery.
    Ng D; Hutchinson S; Pohl M; Powell B
    J Plast Reconstr Aesthet Surg; 2007; 60(6):631-4. PubMed ID: 17485050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant melanoma: perspectives, diagnostics and treatment.
    Shokrollahi K; Whitaker I
    Ann Plast Surg; 2010 Feb; 64(2):132-3. PubMed ID: 20098088
    [No Abstract]   [Full Text] [Related]  

  • 14. The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3).
    Nowecki ZI; Rutkowski P; Michej W
    Ann Surg Oncol; 2008 Aug; 15(8):2223-34. PubMed ID: 18506535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sentinel node biopsy as a prognostic factor in cutaneous melanoma].
    Avilés-Izquierdo JA; Lázaro-Ochaita P
    Actas Dermosifiliogr; 2009; 100(6):486-92. PubMed ID: 19709553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Really synchronous cutaneous melanomas: serendipity or need for prevention?
    Betti R; Gualandri L; Vergani R; Menni S; Crosti C
    Eur J Dermatol; 2009; 19(3):258-9. PubMed ID: 19251563
    [No Abstract]   [Full Text] [Related]  

  • 17. Current concepts in cutaneous melanoma: malignant melanoma.
    Doben AR; MacGillivray DC
    Surg Clin North Am; 2009 Jun; 89(3):713-25. PubMed ID: 19465207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sentinel node biopsy in malignant melanoma: Swedish experiences 1997-2005.
    Mattsson J; Bergkvist L; Abdiu A; Aili Low JF; Naredi P; Ullberg K; Garpered U; Håkansson A; Ingvar C
    Acta Oncol; 2008; 47(8):1519-25. PubMed ID: 18941953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of patients with melanoma and histologically negative sentinel lymph nodes: one institution's experience.
    De Giorgi V; Leporatti G; Massi D; Lo Russo G; Sestini S; Dini M; Lotti T
    Oncology; 2007; 73(5-6):401-6. PubMed ID: 18515980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preface. Melanoma.
    Gershenwald JE
    Surg Oncol Clin N Am; 2011 Jan; 20(1):xv-xvi. PubMed ID: 21111955
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.